MacroGenics Statistics
NASDAQ: MGNXHealth CareBiotechnology: Pharmaceutical PreparationsUSD
3.55-0.09 (-2.47%)
At close: Oct 7, 4:00 PM ET · Delayed 15 min
After hours: 3.55 0.00%
MacroGenics by the numbers
MacroGenics has a market capitalization of $226.1 million based on 63.70M shares outstanding. With trailing EPS of $-1.70, MacroGenics is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 11.1% below its 50-day average and 8.0% above its 200-day average.
Average daily trading volume is 624.72K shares, or about $2.2 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
MGNX valuation vs. peer median
| Metric | MGNX | Peer median | Difference |
|---|---|---|---|
| Market cap | $226.14M | $232.13M | -3% |
| Avg. volume | 624.72K | 705.91K | -12% |
Peer median across 8 companies: PRQR, IFRX, SIGA, SLGL, GLSI, QTTB, EVMN, VOGX.
Valuation
- Market cap
- $226.14M
- EPS (TTM)
- $-1.70
- Shares outstanding
- 63.70M
Price and trading
- Previous close
- 3.64
- Open
- 3.60
- Day range
- 3.53 – 3.73
- 52-week range
- 1.29 – 5.08
- 52-week change
- +106.40%
- Beta
- —
- Volume
- 509.63K
- Average volume
- 624.72K
Dividends and events
- Annual dividend
- None
- Next earnings date
- Nov 12, 2026
Additional statistics
- Market Cap
- 226.14M
- Forward Pe
- -2.42
- Eps
- -1.70
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 5.08
- Week52 Low
- 1.29
- Avg Volume
- 624.72K
- Shares Outstanding
- 63.70M
- Ma50
- 4.00
- Ma200
- 3.29
- Earnings Date
- Nov 12, 2026
- Pct From52w High
- -30.12%
- Pct From52w Low
- 175.19%